Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Bronchial asthma is the disease extended around the world, having optimized medical approaches to which maintaining, it is possible to reduce it’s influence on the patient and society. Approaches applied now to a cumulative assessment of asthma burden are unreliable: doctors underestimate real weight of a disease at the patients receiving antiasthmatic therapy, and patients overestimate extent of control of the disease. However, control of bronchial asthma can be reached with treatment according to the modern recommendations. Article is devoted to some aspects of the combined anti-inflammatory therapy of bronchial asthma by various pharmacological means and their combinations.

Full Text

Restricted Access

About the authors

O M Kurbacheva

Institute of Immunology

Moscow, Russia


  1. Busse W.W., Lemanske R.F. Jr. N. Engl. J. Med. 2001, v. 344, p. 350-362.
  2. Luskin A.T J. Allergy Clin. Immunol. 2005, v. 115, S539-S545.
  3. GINA. Global Strategy for Asthma Management and Prévention 2007.
  4. NAEPP, NHLBI, NIH. NIH publication 07-4051. Published August 2007. asthgdln.pdf.
  5. Bousquet J. et al. Allergy. 2007, v. 62, p. 102-112.
  6. Kwok M.Y et al. Pediatr. 2006, v. 117, p. 71-77.
  7. Partridge M.R. et al. BMC Pulm. Med. 2006, v. 6, p. 13.
  8. LaForest L. et al. Int. Arch. Allergy Immunol. 2005, v. 136, p. 281-286.
  9. Valovirta E. et al. BMC Pulm. Med. 2006, v. 6 (suppl 1), p. 3.
  10. The Workshop Expert Panel. Management of Allergic Rhinitis and its Impact on Asthma (ARIA) Pocket Guide. A Pocket Guide for Physicians and Nurses, 2001.
  11. Kay A.B. Allergy and allergic diseases. First of two parts. N Engl. J. Med. 2001, v. 344, p. 30-37.
  12. Varner A.E., Lemanske R.F. Jr. The early and late asthmatic response to allergen. In: Busse WW Holgate ST eds. Asthma and Rhinitis. 2nd ed. Oxford, UK: Blackwell Science. 2000, p. 1172-1185.
  13. Togias A. Unique mechanistic features of allergic rhinitis. J. Allergy Clin. Immunol. 2000.
  14. Louis R., Lau L.C.K., Bron A.O. et al. The relationship between airways inflammation and asthma severity. Am. J. Respir. Crit. Care Med. 2000, v. 161, p. 9-16.
  15. McLeish A.C. et al. J. Asthma. 2010, v. 47, p. 345-361.
  16. Thomson N.C. et al. Eur. Respir J. 2004, v. 24, p. 822-833.
  17. Jang A.S. et al. J. Korean Med. Sci. 2009, v. 24, p. 209-214.
  18. Price D., Thomas M. BMC Pulm. Med. 2006, v. 6 (suppl 1), p. 6.
  19. Zwarenstein M. et al. BMJ. 2008, v. 337, p. 2390.
  20. Virchow J.C. et al. Add-on montelukast in inadequately controlled asthma patients in а б-month open-label study: The MONtelukast In Chronic Asthma (МОХ1СА) study. Respir Med. 2010, v. 104, p. 644-651.
  21. Virchow J.C. et al. А suberoup analysis of the MONICA study: А 12-month open-label study of add-on montelukast treatment in asthma patients. Published online ahead of print
  22. September 2010. J. Asthma 2010. doi: 10.3109/02770903. 2010.494753.
  23. Masoli M. et al. Allergy. 2004, v. 59 (5), p. 469-478.
  24. World Health Organization/European Environment and Health Information System. Fact Sheet No. 3.1. May 2007. factsheet 3 1.pdf. Accessed
  25. August 2010.
  26. Cazzoletti L. et al. J Allergy Clinlmmunol. 2007, v. 120 (6), p. 1360-1367.
  27. Summit for Change in Asthma Management. The Brussels Declaration. 1st ed. May 2007. Brussels Declaration 1st Edition 10th May.pdf. Accessed 23 August 2010.
  28. Holgate S. et al. Eur. Respir. J. 2008, v. 32, p. 1433-1442.



Abstract: 134

Article Metrics

Metrics Loading ...



Copyright © Pharmarus Print Media, 2012

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies